P3 Health Partners (PIII) had the highest return between April 13, 2023 and May 30, 2023 by a mid-cap US stock, returning 270.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
P3 Health Partners (PIII) | 4/13/2023 - 5/30/2023 | 270.18% |
SS Innovations International Inc Common Stock (SSII) | 4/13/2023 - 5/30/2023 | 120.63% |
D-Wave Quantum (QBTS) | 4/13/2023 - 5/30/2023 | 113.64% |
Arlington Asset Investment (AI) | 4/13/2023 - 5/30/2023 | 98.87% |
Rigetti Computing (RGTI) | 4/13/2023 - 5/30/2023 | 94.34% |
Soleno Therapeutics (SLNO) | 4/13/2023 - 5/30/2023 | 80.81% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 4/13/2023 - 5/30/2023 | 75.74% |
Upstart Holdings (UPST) | 4/13/2023 - 5/30/2023 | 74.61% |
Avepoint (AVPT) | 4/13/2023 - 5/30/2023 | 64.87% |
IONQ (IONQ) | 4/13/2023 - 5/30/2023 | 64.77% |
Nuvalent (NUVL) | 4/13/2023 - 5/30/2023 | 61.2% |
Immunitybio (IBRX) | 4/13/2023 - 5/30/2023 | 60.65% |
Credo Technology (CRDO) | 4/13/2023 - 5/30/2023 | 57.42% |
Arcellx (ACLX) | 4/13/2023 - 5/30/2023 | 53.23% |
Crispr Therapeutics (CRSP) | 4/13/2023 - 5/30/2023 | 46.09% |
Powell Industries (POWL) | 4/13/2023 - 5/30/2023 | 43.56% |
Immunovant (IMVT) | 4/13/2023 - 5/30/2023 | 43.36% |
Celsius (CELH) | 4/13/2023 - 5/30/2023 | 43.11% |
WM Technology (MAPSW) | 4/13/2023 - 5/30/2023 | 42.37% |
Recursion Pharmaceuticals (RXRX) | 4/13/2023 - 5/30/2023 | 42.26% |
MoonLake Immunotherapeutics (MLTX) | 4/13/2023 - 5/30/2023 | 40.43% |
ACV Auctions (ACVA) | 4/13/2023 - 5/30/2023 | 40.11% |
Vaxcyte (PCVX) | 4/13/2023 - 5/30/2023 | 39.57% |
Crinetics Pharmaceuticals (CRNX) | 4/13/2023 - 5/30/2023 | 39.38% |
Krystal Biotech (KRYS) | 4/13/2023 - 5/30/2023 | 38.44% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
